The new trial makes mRNA vaccines personalized, taking an individual’s unique tumor cells. Seven out of the study’s eight ...

The novel personalized mRNA vaccine also demonstrates the potential for such vaccines in other solid tumor types.

This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s ...

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat. CAMBRIDGE, MA / ACC ...

There is some promising news for pancreatic cancer research, as medical data show lasting results from the trial of a vaccine ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

Some promising things are happening in health news, including a possible personalized vaccine against pancreatic cancer. Hear ...

Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...

Almost half of the participants in an early trial of an mRNA-based vaccine to fight pancreatic cancer were alive and well up ...